Neuroactive Amino Acid Profile in Autism Spectrum Disorder: Results from a Clinical Sample

• Main Authors: Martina Randazzo (Author), Adriana Prato (Author), MariaAnna Messina (Author), Concetta Meli (Author), Antonino Casabona (Author), Renata Rizzo (Author), Rita Barone (Author)
• Format: Book
• Published: MDPI AG, 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

Biological bases of autism spectrum disorder (ASD) include both genetic and epigenetic causes. Patients with ASD show anomalies in the profile of certain plasma amino acids, including neuroactive amino acids. Monitoring plasma amino acids may be relevant for patient care and interventions. We evaluated the plasma amino acid profile in samples extracted from dry blood spots by electrospray ionization-tandem mass spectrometry. Fourteen amino acids and eleven amino acid ratios were examined in patients with ASD and intellectual disability (ID), and neurotypical control subjects (TD). The amino acid profile in the ASD group showed reduced levels of ornithine (<i>p</i> = 0.008), phenylalanine (<i>p</i> = 0.042) and tyrosine (<i>p</i> = 0.013). The statistically significant amino acid ratios were Leu+Val/Phe+Tyr (<i>p</i> = 0.002), Tyr/Leu (<i>p</i> = 0.007) and Val/Phe (<i>p</i> = 0.028), such differences remaining significant only in the comparison between ASD and TD. Finally, a positive correlation emerged between the score of the restricted and repetitive behavior on ADOS-2 and the citrulline levels in the ASD group (<i>p</i> = 0.0047). To conclude, patients with ASD may show a distinguishable metabolic profile useful for studying their metabolic pathways in order to develop screening tests and targeted therapies.

Item Description

10.3390/children10020412
2227-9067